ArticleTrials2020

Rivaroxaban compared to no treatment in ER-negative stage I-III early breast cancer patients (the TIP Trial): study protocol for a phase II preoperative window-of-opportunity study design randomised controlled trial.

John Castle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.